Ann M Romaker , MD

BA: University Of Michigan Medical School Ann Arbor, MI, 1975

MD: University Of Michigan Medical School Ann Arbor, MI, 1978 (Medicine)

Henry Ford Hospital, Detroit, MI, 1978 (Intern, Internal Medicine)

Henry Ford Hospital Detroit, MI, 1979 (Resident, Internal Medicine)

UCSD Medical Center, San Diego, CA, 1982 (Pulm/CC Fellowship)

Stanford University Palo Alto, CA, 1984 (Sleep Disorders Med Fellowship)

UCSD Medical Center San Diego, CA, 1984 (Pulm Med Research Fellow)

American Board of Internal Medicine (Certification Date: 09-15-1982 )

American Board of Internal Medicine (Pulmonary Disease) (Certification Date: 11-13-1984 )

Internal Medicine

Lung Disease

Pulmonary Disease

Sleep Medicine

Apnea

Central sleep apnea

Chronic Cough

Diaphragmatic Hernia

Dyspnea

Histoplasmosis

Hypercapnia

Hypoventilation

Insomnia

Legionnaires' Disease (Legionellosis)

Narcolepsy

Neuromuscular pulmonary disease

Obesity Hypoventilation Syndrome

Obstructive sleep apnea

Obstructive Sleep Apnea and Sleep Disordered Breathing

Pleurisy

Pneumonia

REM behavior disorders

REM Sleep Behavior Disorder

Respiration Disorders

Respiratory Syncytial Virus (RSV)

Respiratory Tract Disease

Respiratory Tract Infections

Restless Legs Syndrome

Shortness of Breath

Thoracic Disease

Tuberculosis

Whooping Cough (Pertussis)

Internal Medicine

Sleep Medicine

Grant: #VA IPA-Romaker Investigators:Romaker, Ann 12-01-2014 -11-30-2015 Department of Veterans Affairs Romaker VA IPA Role:PI $119,411.00 Active Level:Federal

Grant: #60059059 / UG3HL140144 Investigators:Romaker, Ann 09-01-2019 -08-31-2020 National Heart, Lung and Blood Institute Impact of Low Flow Nocturnal Oxygen Therapy On Hospital Readmission/Mortality in Patients with Heart Failure and Central Sleep Apneal (LOFT-HF) Role:PI $66,128.00 Awarded Level:Federal

Grant: #Duke; WBSE 383001278; SPS 282235; 10T2HL156812-01; RECOVER SLEEP Investigators:Foot, Rachel; Romaker, Ann 09-25-2023 -12-31-2024 National Heart, Lung and Blood Institute RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Role:PI 55001.47 Hold Level:Federal

Grant: #APC-APN-305 Investigators:Romaker, Ann 03-12-2024 -03-12-2027 Apnimed, Inc. APC-APN-305-PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED 6-MONTH PARALLEL-ARM STUDY TO COMPARE A FIXED DOSE COMBINATION OF AROXYBUTYNIN/ATOMOXETINE (AD109) TO PLACEBO IN OBSTRUCTIVE SLEEP APNEA Role:PI 188033.97 Hold

Academic - Medical Sciences Building 6053
231 Albert Sabin Way
Cincinnati  Ohio, 45267
Phone: 513-558-4831
pulmonary@uc.edu